To the best of our knowledge, our study is the up-to-date meta-analysis evaluating the association between TERT promoter mutation and clinical behaviors in PTC, and it is the first meta-analysis independently investigating the association between TERT promoter mutations and clinical behaviors in FTC. This evidence concerns the gene TERT and thyroid cancer, nonmedullary, 2.